Scott Richards – Non-Executive Director

Scott Richards brings over 35 years of international experience in the pharmaceutical industry to his current role as Chief Executive Officer of Envision Sciences, a privately held precision medicine company focused on advanced diagnostic and prognostic solutions in oncology. Scott has diverse global pharma experience, holding various leadership positions in multiple international jurisdictions, including as Managing Director and CEO of ASX-listed Mayne Pharma Limited from 2012 to 2022. Scott also served as President for Europe, Middle East, and Africa, and later as President of Global Commercial Operations for Mayne Pharma Limited. He also joined the Group Management Board of Actavis, overseeing global injectable/hospital business operations. Scott’s earlier career includes significant roles at FH Faulding and Co, where he led operations in Asia Pacific, and several years in the United States focusing on business development and portfolio management.